PGAP3 Antikörper (N-Term)
Kurzübersicht für PGAP3 Antikörper (N-Term) (ABIN635756)
Target
Alle PGAP3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- PERLD1 antibody was raised against the N terminal of PERLD1
-
Aufreinigung
- Affinity purified
-
Immunogen
- PERLD1 antibody was raised using the N terminal of PERLD1 corresponding to a region with amino acids AGLAARLVLLAGAAALASGSQGDREPVYRDCVLQCEEQNCSGGALNHFRS
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PERLD1 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this PERLD1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PERLD1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PGAP3 (Post-GPI Attachment To Proteins 3 (PGAP3))
-
Andere Bezeichnung
- PERLD1
-
Hintergrund
- PERLD1 is involved in the lipid remodeling steps of GPI-anchor maturation. Lipid remodeling steps consist in the generation of 2 saturated fatty chains at the sn-2 position of GPI-anchors proteins.
-
Molekulargewicht
- 36 kDa (MW of target protein)
-
Pathways
- Inositol Metabolic Process
Target
-